SARTORIUS AG |
Market Closed -
Other stock markets
|
Pre-market 01:52:03 am | |||
| 253 EUR | -3.51% |
|
253 | -0.02% |
| May. 23 | Ailing hospitals slow down German medical technology sector | DP |
| May. 22 | JPMorgan lowers target for Sartorius to 330 euros - 'Overweight' | DP |
Valuation
| Fiscal Period: December | 2024 | 2025 | 2026 |
|---|---|---|---|
| Capitalization 1 | 15,685 | - | - |
| Enterprise Value (EV) 1 | 19,738 | 19,503 | 19,137 |
| P/E ratio | - | - | - |
| Yield | - | - | - |
| Capitalization / Revenue | 4.4 x | 3.93 x | 3.51 x |
| EV / Revenue | 5.54 x | 4.88 x | 4.29 x |
| EV / EBITDA | 18.7 x | 15.6 x | 13.1 x |
| EV / FCF | 66.5 x | 42.9 x | 32.6 x |
| FCF Yield | 1.5% | 2.33% | 3.07% |
| Price to Book | - | - | - |
| Nbr of stocks (in thousands) | 69,029 | - | - |
| Reference price 2 | - | - | - |
| Announcement Date | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,827 | 2,336 | 3,449 | 4,175 | 3,396 | 3,564 | 3,995 | 4,463 |
| EBITDA 1 | 495.8 | 692.2 | 1,175 | 1,410 | 962.7 | 1,058 | 1,253 | 1,462 |
| EBIT 1 | 398.3 | 456.1 | 903.2 | 1,065 | 503.9 | 679.8 | 864.3 | 1,039 |
| Operating Margin | 21.8% | 19.53% | 26.18% | 25.51% | 14.84% | 19.08% | 21.63% | 23.28% |
| Earnings before Tax (EBT) 1 | 303.2 | 446.7 | 668.4 | 1,182 | 385.9 | 475.8 | 718.7 | 914.2 |
| Net income 1 | 156.7 | 226.3 | 318.9 | 678.1 | 205.2 | 217.7 | 354.7 | 429.6 |
| Net margin | 8.58% | 9.69% | 9.25% | 16.24% | 6.04% | 6.11% | 8.88% | 9.63% |
| EPS 2 | 2.300 | 3.310 | 4.670 | 9.920 | 3.000 | 3.646 | 5.272 | 6.799 |
| Free Cash Flow 1 | 151.6 | 271.3 | 458.6 | 211.6 | 293.9 | 296.8 | 454.3 | 586.7 |
| FCF margin | 8.3% | 11.61% | 13.3% | 5.07% | 8.66% | 8.33% | 11.37% | 13.14% |
| FCF Conversion (EBITDA) | 30.58% | 39.19% | 39.03% | 15% | 30.53% | 28.04% | 36.25% | 40.14% |
| FCF Conversion (Net income) | 96.76% | 119.89% | 143.83% | 31.2% | 143.23% | 136.31% | 128.08% | 136.55% |
| Dividend per Share 2 | 0.7100 | 0.7100 | 1.260 | 1.440 | 0.7400 | 0.8875 | 1.114 | 1.349 |
| Announcement Date | 1/28/20 | 1/27/21 | 1/27/22 | 1/26/23 | 1/26/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,057 | 922.3 | 1,025 | 1,036 | 2,060 | 1,053 | 1,062 | 903.2 | 831.8 | 810.7 | 849.8 | 819.6 | 844.7 | 904.2 | 949.4 | - | - |
| EBITDA 1 | 293.5 | 308.6 | 349 | 348.5 | 697.5 | 354 | 358.9 | 271.9 | 245.1 | 216.7 | 229.3 | 234.4 | 226.5 | 255.5 | 290.6 | - | - |
| EBIT 1 | 214.4 | 230.6 | 278.7 | 276 | - | 272.4 | 237.6 | 178.5 | 125.4 | 80 | 120 | 122.3 | 151.6 | 180.5 | 213.7 | - | - |
| Operating Margin | 20.29% | 25% | 27.2% | 26.65% | - | 25.88% | 22.38% | 19.76% | 15.08% | 9.87% | 14.12% | 14.92% | 17.94% | 19.97% | 22.51% | - | - |
| Earnings before Tax (EBT) 1 | 168 | 69.22 | 350.6 | 297.2 | - | - | 252 | 166.3 | 156.7 | 22 | 40.8 | 73.1 | 155.2 | 179.2 | 208.1 | - | - |
| Net income 1 | 81.1 | 23.49 | 205.6 | 165.8 | - | 154.2 | 152.4 | - | - | 8.6 | 8.4 | 36.7 | 49.22 | 60.97 | 88.73 | - | - |
| Net margin | 7.67% | 2.55% | 20.06% | 16.01% | - | 14.65% | 14.35% | - | - | 1.06% | 0.99% | 4.48% | 5.83% | 6.74% | 9.35% | - | - |
| EPS 2 | 1.190 | 0.3500 | 3.010 | 2.420 | - | 2.250 | 2.230 | 1.370 | 1.390 | 0.1300 | 0.1100 | 0.5400 | 0.7452 | 0.9233 | 1.276 | - | - |
| Dividend per Share 2 | - | 1.260 | - | - | - | - | 1.440 | - | 1.440 | - | 0.7400 | - | 0.2370 | 0.2370 | 0.2370 | 0.2595 | 0.2595 |
| Announcement Date | 7/21/20 | 1/27/22 | 4/21/22 | 7/21/22 | 7/21/22 | 10/19/22 | 1/26/23 | 4/20/23 | 7/21/23 | 10/19/23 | 1/26/24 | 4/18/24 | - | - | - | - | - |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 1,011 | 1,884 | 1,733 | 2,375 | 4,932 | 4,053 | 3,818 | 3,452 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 2.04 x | 2.721 x | 1.475 x | 1.684 x | 5.123 x | 3.83 x | 3.046 x | 2.362 x |
| Free Cash Flow 1 | 152 | 271 | 459 | 212 | 294 | 297 | 454 | 587 |
| ROE (net income / shareholders' equity) | 27% | 29.9% | 48.3% | 40.3% | 16.7% | 10.7% | 11.6% | 13.3% |
| ROA (Net income/ Total Assets) | 7.79% | 5.98% | 6.26% | 10.3% | 4.05% | 2.32% | 3.29% | 4.26% |
| Assets 1 | 2,011 | 3,783 | 5,091 | 6,557 | 5,072 | 9,366 | 10,791 | 10,084 |
| Book Value Per Share 2 | 11.90 | 15.30 | 18.40 | 26.60 | 30.20 | 43.20 | 47.50 | 53.50 |
| Cash Flow per Share 2 | 5.520 | 7.480 | 25.30 | 10.70 | 12.50 | 11.90 | 12.70 | 13.10 |
| Capex 1 | 226 | 240 | 407 | 523 | 560 | 453 | 447 | 432 |
| Capex / Sales | 12.35% | 10.29% | 11.8% | 12.52% | 16.48% | 12.71% | 11.18% | 9.68% |
| Announcement Date | 1/28/20 | 1/27/21 | 1/27/22 | 1/26/23 | 1/26/24 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
-EUR
Average target price
325.8
EUR
Spread / Average Target
+∞%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -24.07% | 17.02B | |
| -42.47% | 2.84B | |
| +13.40% | 1.8B | |
| -10.21% | 1.5B | |
| +32.69% | 1.33B | |
| -21.01% | 911M | |
| -25.79% | 849M | |
| +5.15% | 824M | |
| -27.85% | 604M | |
| +19.81% | 569M |
- Stock Market
- Equities
- SRT3 Stock
- Financials Sartorius AG
